2023-12-31-accounts - Erase Meso

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Erase Meso Annual Report period ending 31[st] December 2023

Registered Charity Number: 1183208 Registered Address: 4 Capern Road, London SW18 3EE

Trustees During 2023

Paul Cook Appointed 1[st] May 2019 Richard Bath Appointed 1[st] May 2019 Wayne O’Neil Appointed 1[st] May 2019

Objectives

The objects of Erase Meso (EM) are to promote and protect the physical and mental health of existing and future sufferers of Mesothelioma throughout the world through:

Provision of financial assistance to scientific research aimed at finding a cure for Mesothelioma and/or controlling the non-financial impact of the disease on existing and future sufferers.
Advancement of education and awareness of the general public in all areas relating to Mesothelioma.

Governance

EM is a Charitable Incorporated Organisation, established on 1[st] May 2019, and operating according to a Constitution based on the ‘foundation’ model.

The charity trustees, listed above, make all key decisions and are the only voting members of the Organisation.

The trustees meet regularly to discuss both operational activities of EM and strategic initiatives and direction.

Events and Activities

During 2023 the Trustees continued the process for establishing a Research Advisory Board to aid with the identification and selection of research projects to fund in line with the EM’s charity’s objectives.

In addition, Erase Meso contributed £37,973 for a research grant administered by Mesothelioma UK (Charity No. 1177039) and continued to efforts to build partnerships with related charities.

Minimal fundraising events and activities took place in 2023, with £5,040 received in donations.

Accounts

EM prepare accounts on a receipts and payments basis in line with Charities Commissions requirements.

For the period 1[st] January 2023 to 31[st] December 2023 funds of £5,040 were raised from events and donations.

Payments of £39,465 were deducted, predominantly from £37,973 of grant funding for research into Mesothelioma. The remaining payments of £1,492 related to liability insurance, IT licences and fees deducted by payment and fundraising platforms. EM operates on a volunteer basis, and as such no payments were made for management or advisory services during 2023.

Overall excess of payments over receipts was £34,426, reducing cash and equivalents held at balance date.

Other

The Trustees would like to express our sincere gratitude to all who have supported EM in our endeavour to raise funds for scientific research and to raise awareness of mesothelioma.

Signed on behalf of the Trustees

Paul Cook (Trustee)

Richard Bath (Trustee)

1183208

Erase Meso

Recei ts and a ments accounts p p y

CC16a

For the period from	1st January 2023	To	31st December

Section A Receipts and payments

A1 Receipts	Unrestricted funds to the nearest £ 5,040 - - - - - - - 5,040 - - - 5,040 1,492 37,973 - - - - - - - 39,465 - - - 39,465 - 34,425 - 203,369 168,944	Restricted funds to the nearest £ - - - - - - - - -	Endowment funds to the nearest £ - - - - - - - - -	Total funds to the nearest £ 5,040 - - - - - - - 5,040	Last year to the nearest £
Donations	5,040				19,024
	-				-
	-				-
	-				-
	-				-
	-				-
	-				-
	-				-
*Sub total*(Gross income for AR)	5,040				19,024

A2 Asset and investment sales, (see table).
	-	-	-	-
	-	-	-	-	-
~~*Sub total*~~	-	-	-	-	-
*Total receipts* A3 Payments
					19,024

Admin expenses	1,492				1,793
Grants	37,973				-
	-				-
	-				-
	-				-
	-				-
	-				-
	-				-
	-				-
**Sub total **	39,465				1,793

A4 Asset and investment purchases, (see table)
	-
	-
**Sub total **	-				-
*Total payments* *Net of receipts/(payments)* A5 Transfers between funds A6 Cash funds last year end *Cash funds this year end*
					1,793

	- 34,425	-		- 34,425	17,231
	-	-		-	-
	203,369	-		203,370	-
	168,944	-		Cross Add Error	17,231

Section B Statement of assets and liabilities at	Section B Statement of assets and liabilities at	the end of the period	the end of the period
Categories B1 Cash funds CCXX R1 accounts (SS)	Bank accounts & Equivelents Details 1	Unrestricted funds to nearest £ 168,944	Restricted funds to nearest £ -	Endowment funds to nearest £
	Bank accounts & Equivelents 1	168,944	-	- 31/10/2024

			-
			-
			-
			OK
			Endowment funds to nearest £
			-
			-
			-
			-
			-
			-
			Current value (optional)
			-
			-
			-
			-
			-
			Current value (optional)
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
		-	-
Details	Fund to which liability relates	Amount due (optional)	When due (optional)
		-
		-
		-
		-
		-
Signature	Print Name Richard Bath
			Date of approval
	Richard Bath		31/10/2024

CCXX R2 accounts (SS)

31/10/2024